Melanoma Tissue Bank Consortium

Analysis

Melanoma Tissue Bank Consortium is a registered charity in United States, based in Sacramento, CA. It received its IRS tax-exemption ruling in July 2013, 13 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Melanoma Tissue Bank Consortium reported income of $596k and spending of $245k, leaving 59% of income unspent that year. Across the 5 years on record, from December 2019 to December 2023, income grew from $234k to $596k (+155%), an average of +26% a year. The sharpest change came in the year to December 2021, when income rose by 154%. Over the whole period it spent 44% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Melanoma Tissue Bank Consortium sits at the 57th percentile: it is larger than about 57% of them. Against every charity in United States with reported income it ranks in the 73rd percentile, and in the 74th percentile within CA. Charities of a similar size with the same main cause include Anphon Corporation ($596k), Plainview Foundation for Rural Health Advancement ($596k) and Cobb Memorial Foundation Inc ($596k).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 96% of the total. At year end it held assets of $1.7m against liabilities of $0, net assets of $1.7m.